tiprankstipranks
Trending News
More News >
Elanco Animal Health (ELAN)
NYSE:ELAN
US Market
Advertisement

Elanco Animal Health (ELAN) Earnings Dates, Call Summary & Reports

Compare
444 Followers

Earnings Data

Report Date
Feb 25, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.12
Last Year’s EPS
0.14
Same Quarter Last Year
Based on 9 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 05, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
Elanco reported strong financial results for Q3 2025 with significant revenue growth from both farm and pet health segments. The company achieved notable success with innovation products, particularly Credelio Quattro. However, challenges in pricing growth and tempered Bovaer adoption were noted. Overall, the sentiment is positive, driven by strong performance and strategic achievements.
Company Guidance
During Elanco Animal Health's Third Quarter 2025 earnings call, the company reported a 9% organic constant currency revenue growth, surpassing the high end of their guidance for revenue, adjusted EBITDA, and adjusted EPS. The growth was primarily driven by a 20% increase in U.S. Farm Animal sales and a 9% rise in U.S. pet health. Innovation remains a key focus, with year-to-date revenue from innovative products reaching $655 million, leading to an upward revision of full-year expectations to $840-$880 million. The company also improved its net leverage ratio to 3.7x at quarter-end, with expectations to maintain it between 3.7x and 3.8x by year-end. Elanco successfully refinanced its $2.1 billion Term Loan B facility, extending maturities to 2032. Despite potential tariff risks, the company expects a net impact of $10-$14 million in 2025, with mitigation strategies in place. For the full year, Elanco now anticipates organic constant currency growth of 6%-6.5%, adjusted EBITDA of $880-$900 million, and adjusted EPS of $0.91-$0.94.
Strong Organic Revenue Growth
Elanco achieved 9% organic constant currency revenue growth in Q3 2025, outperforming the high end of guidance for revenue, adjusted EBITDA, and adjusted EPS.
U.S. Farm and Pet Health Growth
U.S. Farm Animal segment grew by 20% and U.S. pet health grew by 9%, marking the 9th consecutive quarter of underlying total growth.
Innovation Revenue Increase
Innovation products achieved $655 million in year-to-date revenue, exceeding expectations and leading to a full-year guidance increase by $100 million.
Credelio Quattro Success
Credelio Quattro reached blockbuster status with $100 million in sales in less than 8 months, driven by strong demand and differentiation.
Improved Leverage Ratio
Elanco improved its net leverage ratio to 3.7x by the end of Q3 2025, faster than planned, with expectations to end the year between 3.7x and 3.8x.
Refinancing of Term Loan B
Successfully refinanced $2.1 billion Term Loan B facility, extending maturities through 2032, improving the capital structure.

Elanco Animal Health (ELAN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ELAN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 25, 2026
2025 (Q4)
0.12 / -
0.14
Nov 05, 2025
2025 (Q3)
0.13 / 0.19
0.1346.15% (+0.06)
Aug 07, 2025
2025 (Q2)
0.20 / 0.26
0.3-13.33% (-0.04)
May 07, 2025
2025 (Q1)
0.31 / 0.37
0.348.82% (+0.03)
Feb 25, 2025
2024 (Q4)
0.15 / 0.14
0.0875.00% (+0.06)
Nov 07, 2024
2024 (Q3)
0.12 / 0.13
0.18-27.78% (-0.05)
Aug 08, 2024
2024 (Q2)
0.24 / 0.30
0.1866.67% (+0.12)
May 08, 2024
2024 (Q1)
0.27 / 0.34
0.45-24.44% (-0.11)
Feb 26, 2024
2023 (Q4)
0.10 / 0.08
0.19-57.89% (-0.11)
Nov 07, 2023
2023 (Q3)
0.13 / 0.18
0.2-10.00% (-0.02)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

ELAN Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 05, 2025
$22.50$21.60-4.00%
Aug 07, 2025
$13.95$16.48+18.14%
May 07, 2025
$9.51$12.01+26.29%
Feb 25, 2025
$11.11$10.70-3.69%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Elanco Animal Health (ELAN) report earnings?
Elanco Animal Health (ELAN) is schdueled to report earning on Feb 25, 2026, Before Open (Confirmed).
    What is Elanco Animal Health (ELAN) earnings time?
    Elanco Animal Health (ELAN) earnings time is at Feb 25, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ELAN EPS forecast?
          ELAN EPS forecast for the fiscal quarter 2025 (Q4) is 0.12.

            Elanco Animal Health (ELAN) Earnings News

            ELAN Earnings: Elanco Ticks Lower on Mixed Q4 Performance
            Premium
            Market News
            ELAN Earnings: Elanco Ticks Lower on Mixed Q4 Performance
            2y ago
            Elanco (NYSE:ELAN) Gains On Robust Q2 Showing; Boosts Guidance
            Premium
            Market News
            Elanco (NYSE:ELAN) Gains On Robust Q2 Showing; Boosts Guidance
            2y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis